This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Ionis Pharmaceuticals, Inc.. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: Mariam Aghajan: Innovator in Modulating TMPRSS6 Expression
Introduction
Mariam Aghajan is a prominent inventor based in San Diego, CA. She has made significant contributions to the field of biotechnology, particularly in the area of modulating TMPRSS6 expression. Her work focuses on addressing iron accumulation diseases, which can have serious health implications for affected individuals.
Latest Patents
Mariam Aghajan holds a patent for "Compounds and methods for modulating TMPRSS6 expression." This patent discloses compositions and compounds that comprise modified oligonucleotides aimed at modulating TMPRSS6. The invention is particularly relevant for treating, ameliorating, delaying, or preventing iron accumulation diseases such as polycythemia, hemochromatosis, and β-thalassemia through the administration of antisense compounds targeted to TMPRSS6. She has 1 patent to her name.
Career Highlights
Mariam Aghajan is currently associated with Ionis Pharmaceuticals, Inc., where she continues to advance her research and innovations. Her work is instrumental in developing therapeutic solutions for complex medical conditions related to iron metabolism.
Collaborations
Mariam collaborates with esteemed colleagues, including Shuling Guo and Eric E Swayze, who contribute to her research endeavors and help drive innovation in the field.
Conclusion
Mariam Aghajan is a trailblazer in the biotechnology sector, with her innovative approaches to modulating TMPRSS6 expression paving the way for new treatments for iron accumulation diseases. Her contributions are vital to advancing medical science and improving patient outcomes.